Neurogene Inc.
NGNE
$20.02
$0.784.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -10.97% | 9.04% | |||
| Gross Profit | 10.97% | -9.04% | |||
| SG&A Expenses | -2.35% | -17.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.75% | 0.63% | |||
| Operating Income | 8.75% | -0.63% | |||
| Income Before Tax | 4.83% | 2.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.83% | 2.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.83% | 2.79% | |||
| EBIT | 8.75% | -0.63% | |||
| EBITDA | 9.05% | -0.62% | |||
| EPS Basic | 5.34% | 3.06% | |||
| Normalized Basic EPS | 5.34% | 3.06% | |||
| EPS Diluted | 5.34% | 3.06% | |||
| Normalized Diluted EPS | 5.34% | 3.06% | |||
| Average Basic Shares Outstanding | 0.54% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||